⌘K

16:52:04·103d

SECFilingvia Quantisnow

Amendment: SEC Form SCHEDULE 13G/A filed by Reviva Pharmaceuticals Holdings Inc.

ByQuantisnow·Wall Street's wire, on your screen.

RVPH· Reviva Pharmaceuticals Holdings Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

RVPH
Reviva Pharmaceuticals Holdings Inc.
Health Care

Recent analyst ratings

Mar 5UpdateD. Boral Capital-
Sep 29UpdateChardan Capital Markets$2.00
Sep 20UpdateROTH MKM$12.00
Jun 8UpdateThe Benchmark Company$17.00
Jan 24UpdateHC Wainwright & Co.$10.00
Jul 26UpdateMaxim Group$10.00

Related

PR6d
Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine's Potential Across Multiple Neuropsychiatric Indications
SEC14d
Reviva Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
PR14d
Reviva Announces Letter to Shareholders
SEC30d
SEC Form SCHEDULE 13G filed by Reviva Pharmaceuticals Holdings Inc.
SEC30d
SEC Form S-8 filed by Reviva Pharmaceuticals Holdings Inc.
SEC30d
Reviva Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
SEC33d
SEC Form 10-K filed by Reviva Pharmaceuticals Holdings Inc.
PR30d
Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights